Casein hydrolysates enhance osteoblast proliferation and differentiation in mouse bone marrow culture

Food Bioscience

Volumn 2, Issue , 2013, Pages 24-30

  Behera, Parthasarathi ^a   Kumar, Raj ^a   Sandeep, I V R ^a   Kapila, Rajeev ^a   Dang, Ajay Kumar ^a   Kapila, Suman ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Bone formation; Casein hydrolysates; Osteoblast proliferation and differentiation

Indexed keywords

EID: 84885096724     PISSN: 22124292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fbio.2013.03.008     Document Type: Article

References (41)

1. AOAC, N. (1984). Official methods of analysis (14th ed. Vol. 877. Washington, DC: Association of Official Agric. Chemistsp. 988.
2. Behera, P. S., Kumar, R., Sandeep, I. V.R., Kapila, R., Dang, A. K., & Kapila, S. (2012). Fractionation and characterisation of alpha, beta and kappa-casein trypsin hydrolysates from Buffalo (Bubalus bubalis) milk. Milchwissenschaft, 67(4), 428-431.
3. Bhattacharjee, S., Bhattacharjee, C., & Datta, S. (2006). Studies on the fractionation of β-lactoglobulin from casein whey using ultrafiltration and ion-exchange membrane chromatography. Journal of Membrane Science, 275(1-2), 141-150.
4. Chee, W. S.S., Suriah, A. R., Chan, S. P., Zaitun, Y., & Chan, Y. M. (2003). The effect of milk supplementation on bone mineral density in postmenopausal Chinese women in Malaysia. Osteoporosis International, 14, 828-834.
5. Cheng, S., Lyytikainen, A., Kroger, H., Lamberg-Allardt, C., Alen, M. Koistinen, A., et al., 2005. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: A 2-y randomized trial. American Society of Clinical Nutrition, 5, 1115-1126.
6. Chomzynski, P., & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156-159.
7. Cushman, D. W., & Cheung, H. S. (1971). Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochemical Pharmacology, 20, 1637-1648.
8. Daniela, R, Laura, D. D., Angiolella, L, Christian, A, Alessandro, N., & Gianfranco, G. (2010). Fermented milks from Enterococcus faecalis TH563 and Lactobacillus delbrueckii subsp. bulgaricus LA2 manifest different degrees of ACE-inhibitory and immunomodulatory activities. Dairy Science and Technology, 90, 469-476.
9. Eisman, J. A. (2004). Osteoporosis risk high in India. Frontline, 21(1), 3-16.
10. Ensrud, K. E., Walczak, T. S., Blackwell, T. L., Ensrud, E. R., Barrett-Connor, E., & Orwoll, E. S. (2008). Antiepileptic drug use and rates of hip bone loss in older men: A prospective study. Neurology, 71, 723-730.
11. Fox, P. F., & Guiney, J. (1972). A procedure for the partial hydrolysis of as-complex. Journal of Dairy Research, 39, 49-53.
12. Haque, E., Chand, R., & Kapila, S. (2009). Biofunctional properties of bioactive peptides of milk origin. Food Reuieujs International, 25(16), 28-43.
13. Hernandez-Ledesma, B., Amigo, L., Ramos, M., & Recio, I. (2004). Angiotensin converting enzyme inhibitory activity in commercial fermented products: Formation of peptides under simulated gastrointestinal digestion. Journal of Agricultural Food Chemistry, 52, 1504-1510.
14. Hofbauer, L. C., & Heufelder, A. E. (2001). Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. Journal of Molecular Medicine, 79, 243-253.
15. Hofbauer, L. C., Neuberger, A., & Heufelder, A. E. (2001). Receptor activator of factor-kappaB ligand and osteoprotegerin: Potential implications for the pathogenesis and treatment of malignant bone disease. Cancer, 92, 460-470.
16. Huttunen, M., Pekkinen, M., Ahlstrom, M., & Lamberg-Allardt, C. (2008). Long-term effects of tripeptide Ile-Pro-Pro on osteoblast differentiation in uitro. Journal of Nutritional Biochemistry, 19, 708-715.
17. Kalkwarf, H. J., Khoury, J. C., & Lanphear, B. P. (2003). Milk intake during childhood and adolescence, adult bone density and osteoporotic fractures in US women. American Journal of Clinical Nutrition, 77, 257-265.
18. Korhonen, H., & Pihlanto, A. (2006). Bioactive peptides: Production and functionality. International Dairy Journal, 16(9), 945-960.
19. Kulak, C. A., & Bilezikian, J. P. (1998). Osteoporosis: Preventive strategies. International Journal of Fertility and Women's Medicine, 43(2), 56-64.
20. Kwok, T., Leung, J., Zhang, Y. F., Bauer, D., Ensrud, K. E. Barrett-Connor, E., et al., 2012. Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?. Osteoporos International, 23, 2159-2167.
21. Lanou, A. J., Berkow, S. E., & Barnard, N. D. (2005). Calcium, dairy products, and bone health in children and young adults: A reevaluation of the evidence. Pediatrics, 115(3), 736-743.
22. Ledford, D., Apter, A., & Brenner, A. M. (1998). Osteoporosis in the corticosteroid-treated patient with asthma. Journal of Allergy and Clinical Immunology, 102(3), 353-362.
23. Lian, J. B., & Gundberg, C. M. (1988). Osteocalcin: Biochemical considerations and clinical applications. Clinical Orthopedic Related Research, 226, 267-291.
24. Lian, J. B., & Stein, G. R. (1992). Concepts of osteoblast growth and differentiation: Basis for modulation of bone cell development and tissue formation. Critical Reuiews in Oral Biology and Medicine, 3(3), 269-305.
25. Lopez-Fandino, R., Otte, J., & Camp, J. V. (2006). Physiological, chemical and technological aspect of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. International Dairy Journal, 16(11), 1277-1293.
26. Malhotra, N., & Mithal, A. (2008). Osteoporosis in Indians Indian. Journal of Medicinal Research, 127, 263-268.
27. Matkovic, V., Landoll, J. D., Badenhop-Stevens, N. E., Ha, E. Y., Crncevic-Orlic, Z. Li, B., et al., 2004. Nutrition influences skeletal development from childhood to adulthood: A study of hip, spine and forearm in adolescent females. Journal of Nutrition, 134, 701S-705S.
28. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
29. Murphy, S., Khaw, K. T., May, H., & Composton, J. E. (1994). Milk consumption and bone mineral density in middle aged and elderly women. British Medical Journal, 308, 939-941.
30. Narva, M., Halleen, J., Vaananen, K., & Korpela, R. (2004). Effects of Lactobacillus helueticus fermented milk on bone cells in uitro. Life Science, 75, 1727-1734.
31. Narva, M., Collin, M., Lamberg-Allardt, C., Karkkainen, M., Poussa, T. Vapaatalo, H, et al., 2004. Effects of long-term intervention with Lactobacillus helueticus-fermented milk on bone mineral density and bone mineral content in growing rats. Annual Nutrition Metabolism, 8, 228-234.
32. Qu, Q., Perala-Heape, M., Kapanen, A., Dahllund, J., Salo, J. Vaananen, H. K., et al., 1998. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone, 22, 201-209.
33. Sila-asna, M., Bunyaratvej, A., Maeda, S., Kitaguchi, H., & Bunyaratavej, N. (2007). Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell. Kobe Journal of Medical Science, 53, 25-35.
34. Stein, G. S., Lian, J. B., Stein, J. L., van Wijnen, A. J., & Montecino, M. (1996). Transcriptional control of osteoblast growth and differentiation. Physiological Reuiews, 76, 593-629.
35. Strauss, P. G., Closs, E. I., Schmidt, J., & Erfle, V. (1990). Gene expression during osteogenic differentiation in mandibular condyles in uitro. Journal of Cell Biology, 110, 1369-1378.
36. Takahshi, N., Udagawa, N., & Suda, T. (1999). A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochemical Biophysical Research Communications, 256, 449-455.
37. Unni, J., Garg, R., & Pawar, R. (2010). Bone mineral density in women above 40 years. Journal of Mid-life Health, 1, 19-22.
38. Xu, R. (2009). Effect of whey protein on the proliferation and differentiation of osteoblasts. Journal of Dairy Science, 92, 3014-3018.
39. Yang, L. J., Shen, F. X., Zheng, J. C., & Zhang, H. L. (2012). Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism. Zhongguo Gu Shang, 25(2), 133-137.
40. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M. Mocchizuki, S., et al., 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proceeding of National Academy of Science, 95, 3597-3602.
41. Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S. I., Yano, K. Fujise, N., et al., 1998. Identity of osteoclastogenesis inhibitory factor (OCIF) and Osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in uitro. Endocrinology, 139, 1329-1337.